Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Immune Interception Approaches for Individuals at Risk for Pancreatic Cancer

  • Date: Wednesday, December 13, 2023
  • Time: 1:00pm EST to 2:00pm EST

Please join the NCI Division of Cancer Prevention Immunology Interest Group (DCP IIG) seminar series talk focused on cancer prevention, interception, and immuno-oncology.

Speaker

Elizabeth M. Jaffee, M.D., FAACR, FACP, FAAAS

Elizabeth M. Jaffee, M.D., FAACR, FACP, FAAAS

The Dana and Albert “Cubby” Broccoli Professor of Oncology
Deputy Director, Sidney Kimmel Cancer Center
Johns Hopkins Medicine

Biography

Dr. Jaffee is an internationally recognized expert in cancer immunology and pancreatic cancer. She is Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Co-Director of the Skip Viragh Pancreatic Cancer Center and Associate Director of the Bloomberg Kimmel Institute for Cancer Immunotherapy. Her research focus is on developing novel immunotherapies for the treatment and prevention of pancreatic cancer. Her recent work has focused on developing novel biomarker driven immunotherapy clinical trials to dissect the complex inflammatory signals within the tumor microenvironment. Through collaborations with computational biologists, her team has identified a number of immune suppressive signals that regulate pancreatic cancer development and progression.

Dr. Jaffee is a Past President of AACR. She has served on a number of committees at the National Cancer Institute, including the co-chair of the Biden Moonshot Blue Ribbon Panel which identified high impact research priorities for the NCI. She currently serves as Chief Medical Advisor to the Lustgarten Foundation for Pancreatic Cancer Research. She is the inaugural director of the Convergence Institute for Integrating Technologies and Computational Sciences at Johns Hopkins. Dr. Jaffee is a member of the National Academy of Medicine, a Fellow of the American College of Physicians, a Fellow of American Association for the Advancement of Science, a Fellow of the SITC Academy of Immuno-Oncology and a Fellow of the AACR Academy. Most recently, she was appointed chair of President Biden’s Cancer Panel.

Dr. Jaffee is passionate about supporting and mentoring women and underrepresented individuals in science and medicine. She has received a number of awards for her efforts including the Assistant Dean’s Award for Women Mentorship, and the Dean’s Mentoring Award.